16 results
S-8
ANIX
Anixa Biosciences Inc
16 Jan 24
Registration of securities for employees
4:43pm
that we may need for the development of our technologies and products.
Cell-based therapies rely on the availability of specialty raw materials, which may … not be available to us on acceptable terms or at all.
Gene-modified cell therapy manufacturing requires many specialty raw materials, some of which
S-8
ANIX
Anixa Biosciences Inc
4 Jan 22
Registration of securities for employees
4:12pm
that we may need for the development of our technologies and products.
Cell-based therapies rely on the availability of specialty raw materials, which … may not be available to us on acceptable terms or at all.
Gene-modified cell therapy manufacture requires many specialty raw materials, some of which
S-8
ANIX
Anixa Biosciences Inc
7 Jan 21
Registration of securities for employees
4:18pm
and products.
Cell-based therapies rely on the availability of specialty raw materials, which may not be available to us on acceptable terms or at all.
Gene … -modified cell therapy manufacture requires many specialty raw materials, some of which are manufactured by small companies with limited resources
10-K
EX-99.1
m7d j4kaa
28 Jan 00
Annual report
12:00am
10-K405
vxwrgjei
29 Jan 98
Annual report (delinquent filer disclosure)
12:00am
10-K405
y27yn 3c5zyr0pft96x
29 Jan 97
Annual report (delinquent filer disclosure)
12:00am
10-K405
mxauiz9l
29 Jan 96
Annual report (delinquent filer disclosure)
12:00am
- Prev
- 1
- Next